- Home
- INM vs FITBO Comparison
INM vs FITBO Comparison
Compare INM & FITBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INM | FITBO |
|---|---|---|
| Founded | 1981 | N/A |
| Country | Canada | United States |
| Employees | N/A | 18616 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | N/A |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | INM | FITBO |
|---|---|---|
| Price | $0.60 | $19.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 113.7K | 16.0K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,942,633.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.65 | $19.19 |
| 52 Week High | $7.98 | $22.16 |
Technical Indicators
Market Signals| Indicator | INM | FITBO |
|---|---|---|
| Relative Strength Index (RSI) | 35.01 | 33.32 |
| Support Level | N/A | N/A |
| Resistance Level | $0.94 | $20.20 |
| Average True Range (ATR) | 0.08 | 0.20 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 13.42 | 4.59 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of over $210 billion as of December 2025. The bank is set to close its acquisition of Comercia on Feb. 1, 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.